Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director
|
NexImmune, Inc. (NEXI)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/09/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/07/2022 |
3
| OELKE MATHIAS (Chief Science Officer) has filed a Form 3 on NexImmune, Inc. |
02/11/2021 |
3
| Verstandig Grant (Director) has filed a Form 3 on NexImmune, Inc. |
02/11/2021 |
3
| ZELDIS JEROME B (EVP of R&D) has filed a Form 3 on NexImmune, Inc. |
02/11/2021 |
3
| Yao Zhengbin (Director) has filed a Form 3 on NexImmune, Inc. |
02/11/2021 |
3
| Trainer John (CFO) has filed a Form 3 on NexImmune, Inc. |
02/11/2021 |
3
| Roemer Alan S. (Director) has filed a Form 3 on NexImmune, Inc. |
02/11/2021 |
3
| Knight Robert Douglas (Chief Medical Officer) has filed a Form 3 on NexImmune, Inc. |
02/11/2021 |
3
| Jones Kristi (COO) has filed a Form 3 on NexImmune, Inc. |
02/11/2021 |
3
| D'Angio Paul (Director) has filed a Form 3 on NexImmune, Inc. |
02/11/2021 |
3
| Carmer Scott (President and CEO) has filed a Form 3 on NexImmune, Inc. |
02/11/2021 |
3
| Bertram Timothy (Director) has filed a Form 3 on NexImmune, Inc. |
02/11/2021 |
3
| BARER SOL J (Director) has filed a Form 3 on NexImmune, Inc. |
|
|